New perspectives for the treatment of cholestasis: Lessons from basic science applied clinically
- 31 March 2007
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 46 (3) , 365-371
- https://doi.org/10.1016/j.jhep.2006.12.001
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- OATP8/1B3-mediated Cotransport of Bile Acids and GlutathioneJournal of Biological Chemistry, 2006
- Benefit of farnesoid X receptor inhibition in obstructive cholestasisProceedings of the National Academy of Sciences, 2006
- Pregnane X Receptor Activators Inhibit Human Hepatic Stellate Cell Transdifferentiation In VitroGastroenterology, 2006
- FXR: a target for cholestatic syndromes?Emerging Therapeutic Targets, 2006
- Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronidesJournal of Hepatology, 2005
- Complementary Stimulation of Hepatobiliary Transport and Detoxification Systems by Rifampicin and Ursodeoxycholic Acid in HumansGastroenterology, 2005
- Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanismsJournal of Hepatology, 2004
- Molecular Alterations in Hepatocyte Transport Mechanisms in Acquired Cholestatic Liver DisordersSeminars in Liver Disease, 2000
- Stimulation of bile acid 6α-hydroxylation by rifampinJournal of Hepatology, 1996
- Chenodeoxycholic Acid and Ursodeoxycholic Acid Effects in Endogenous Hypertriglyceridemias. A Controlled Double‐Blind TrialThe Journal of Clinical Pharmacology, 1981